By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Juniper Pharma (Formerly known as Columbia Laboratories) 

4 Liberty Square

Boston  Massachusetts  02109  U.S.A.
Phone: 617-639-1500 Fax: n/a


SEARCH JOBS


Industry
Biotechnology






Company News
Boston's Juniper Pharma (JNP) Terminates Development of Lidocaine Bioadhesive Gel After Phase II Trial Failure 8/18/2016 5:36:32 AM
Juniper Pharma (JNP) Reports Second Quarter 2016 Financial Results 8/4/2016 8:27:56 AM
Juniper Pharma (JNP) To Report Second Quarter 2016 Results On August 4, 2016 7/26/2016 6:57:30 AM
Zafgen (ZFGN)'s Alicia Secor Steps Up as Juniper Pharma (JNP)’s President and CEO 7/20/2016 5:42:21 AM
Juniper Pharma (JNP) Announces Completion Of Enrollment In Phase 2b Clinical Trial Of COL-1077 10% Lidocaine Vaginal Gel For Gynecologic Procedure Pain 7/7/2016 7:22:52 AM
Juniper Pharma (JNP) Announces That Merck KGaA (MKGAF.PK), Darmstadt, Germany, Has Obtained Regulatory Approval For OneCrinone In Japan 7/5/2016 6:19:17 AM
Juniper Pharma (JNP) To Present At Cantor Fitzgerald Healthcare Conference 6/29/2016 11:30:29 AM
Juniper Pharma (JNP) Announces Phase 1 Studies Of COL-1077 Lidocaine Vaginal Gel Published In Peer Reviewed Scientific Journal 6/17/2016 11:10:36 AM
Juniper Pharma (JNP) CEO to Retire Later This Year 6/2/2016 5:50:20 AM
Juniper Pharma (JNP) To Present At Jefferies 2016 Healthcare Conference 5/24/2016 8:43:06 AM
12345678910...
//-->